SCHEMBL20174229

SCHEMBL20174229

c1ccc(-c2nc(-c3cccc(-c4ccc5c(c4)-c4ccccc4C54c5ccccc5-c5oc6ccccc6c54)c3)nc(-c3cccc4ccccc34)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.36
ALDH1A1 P00352 6/20 0.36
HSD17B10 Q99714 5/20 0.36
HPGD P15428 4/20 0.36
KDM4E B2RXH2 4/20 0.36
MAPK1 P28482 3/20 0.36
TSHR P16473 2/20 0.36
ATM Q13315 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
TP53 P04637 1/20 0.36
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
S1PR1 P21453 1/20 0.31
S1PR3 Q99500 1/20 0.31
KMT2A Q03164 3/20 0.31
PLA2G2A P14555 2/20 0.31
PLA2G4A P47712 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20174246 0.92 PLA2G2A (0.34) MAPTALDH1A1HSD17B10HPGDKDM4E
SCHEMBL20174280 0.92 S1PR1 (0.34) MAPTALDH1A1HSD17B10HPGDKDM4E
SCHEMBL20174235 0.91 ALDH1A1 (0.33) MAPTALDH1A1HSD17B10HPGDKDM4E
SCHEMBL20179219 0.90 CA12 (0.31) MAPTALDH1A1HSD17B10HPGDKDM4E
SCHEMBL20174203 0.90 MAPT (0.33) MAPTALDH1A1HSD17B10HPGDKDM4E
SCHEMBL20174276 0.89 PLA2G2A (0.33) MAPTALDH1A1HSD17B10HPGDKDM4E
SCHEMBL20174251 0.89 ALDH1A1 (0.35) MAPTALDH1A1HSD17B10HPGDKDM4E
SCHEMBL20174238 0.88 ALDH1A1 (0.36) MAPTALDH1A1HSD17B10HPGDKDM4E
SCHEMBL20174291 0.88 KMT2A (0.38) MAPTALDH1A1HSD17B10HPGDKDM4E
SCHEMBL22326557 0.88 PDK2 (0.36) MAPTALDH1A1HSD17B10HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738034-B2 Spiro compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2020-08-11 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738034-B2 Spiro compound and organic light-emitting device comprising same CRY1, NR2E3, ERG MAPT 811/4885ALDH1A1 33/4885HSD17B10 1154/4885
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, NR2E3, ERG MAPT 811/4885ALDH1A1 33/4885HSD17B10 1154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.